Skip to main content
logo
Munar Pharma S.A. (WSE:MUN)
Poland flag Poland · Delayed Price · Currency is PLN
0.3090
0.00 (0.00%)
At close: Sep 3, 2026

Munar Pharma Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.250.250.252.162.972.11
Revenue Growth
256.95%-0.34%-88.41%-27.10%40.67%-5.89%
Gross Profit
-0-00.272.383.072.54
Operating Income
-0.72-0.73-0.42-0.970.19-1.12
Net Income
-0.72-0.760.11-4.7-0.34-1.03
Earnings Per Share
-0.02-0.020.01-0.28-0.02-0.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.431.650.020.230.190.61
Total Debt
0.010.010.070.07-0.02
Net Cash (Debt)
1.411.64-0.050.160.190.59
Net Cash Growth
----17.05%-67.05%877.04%
Net Cash Per Share
0.030.03-0.000.010.010.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.6-1.15-1.130.16-0.26-1.68
Capital Expenditures
-0.01-0.01---0.11-
Free Cash Flow
-0.61-1.15-1.130.16-0.36-1.68
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-0.54%-0.52%109.41%109.80%103.39%120.20%
Operating Margin
-289.52%-293.30%-167.75%-44.82%6.46%-52.93%
Pretax Margin
-288.81%-302.38%84.96%-234.20%-22.00%-51.25%
Profit Margin
-288.81%-302.38%45.80%-217.03%-11.46%-48.79%
FCF Margin
-242.79%-461.07%-450.01%7.51%-12.27%-79.78%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--36.05---
P/FCF Ratio
---86.50--
PS Ratio
59.9425.1216.516.496.5210.81